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A leucine zipper motif is conserved in the cytoplasmic domain of glycoprotein gp41 (gp41c) of all HIV-1 subtypes, but
is not present in HIV-2 or SIV. The second leucine residue of the leucine zipper was mutated (L95R) to determine the
role of this motif in HIV-1 replication and pathogenesis. The L95R mutant replicated to wild-type levels in activated
peripheral blood mononuclear cells and CEMx174 cells. However, L95R replication was impaired in SupT1 cells and in
the SCID-hu Thy/Liv mouse. Although the infectivity of wild-type virions and that of L95R mutant virions were equally
sensitive to heat treatment, we found that L95R produced more defective virions, due to reduced surface expression
and virion incorporation of the env glycoprotein. These results suggest that the L95 residue in the leucine zipper of
gp41c of HIV-1 plays an important role in the env expression and virion incorporation that is required for viral replication
and pathogenesis in the SCID-hu Thy/Liv mouse. The leucine zipper motif in gp41c may provide a novel anti-HIV-1
target. © 2001 Academic Press
TINTRODUCTION
Like other lentivirus transmembrane (TM) glycopro-
teins, the TM glycoprotein (gp41) of HIV-1 has a long
cytoplasmic domain of 150 amino acids (residues 704–
854, gp41c). Deletions of gp41c impair HIV-1 replication
and infectivity (Dubay et al., 1992; Gabuzda et al., 1992;
Lee et al., 1989; Yu et al., 1993). The gp41c domains
appear to be required in a cell type-dependent (Akari et
al., 2000; Gabuzda et al., 1992; Murakami and Freed,
2000) and species-dependent fashion (Johnston et al.,
1993; Kodama et al., 1989), suggesting that a host cell
factor is involved. For instance, simian immunodeficiency
virus (SIV) mutants with truncation mutations in gp41c
arise from selection in human cells. However, infection of
rhesus macaque peripheral blood lymphocytes in vitro or
in vivo with the SIV mutant results in rapid reversion to
full-length gp41 (Kodama et al., 1989).
The C-terminal domain of gp41 encodes a Tyr-based
motif that mediates internalization of HIV-1 glycoproteins
via interaction with the AP2 clathrin adaptor protein
(Boge et al., 1998) and two lentivirus lytic peptides (LLPs),
which are capable of binding and disturbing lipid bilay-
ers (Miller et al., 1991). The ability of LLP-1 (residues
768–788) and LLP-2 (residues 826–854) to interact with
lipid bilayers suggests membrane-related functions.
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208LLP-1 also interacts with calmodulin (Miller et al., 1993;
Srinivas et al., 1993) and LLP-2 inhibits Ca21-dependent
-cell activation (Beary et al., 1998), implicating these
amphipathic helices in protein–protein interactions and
signal transduction. A leucine zipper motif (residues
789–815) in HIV-1 gp41c has also been shown to interact
with lipid bilayers (Kliger and Shai, 1997). Mutational
analysis has shown that this amphipathic helix region of
gp41c is involved in its interaction with p115-RhoGEF, a
specific guanine nucleotide exchange factor and activa-
tor of the RhoA GTPase (Zhang et al., 1999).
We examined the role of this leucine zipper in HIV-1
replication and pathogenesis by mutating the second
leucine residue of this motif (L95, amino acid 95 of
gp41c or residue 798 of gp160) to an arginine residue.
The L95R mutant replicated to wild-type (NL4-3) levels
in peripheral blood mononuclear cells (PBMC) and
CEMx174 cells. However, L95R replication was im-
paired in SupT1 cells and in the SCID-hu Thy/Liv
mouse. The L95R mutant env fused efficiently to both
SupT1 and CEMx174 cells and L95R mutant virions
showed wild-type sensitivity to heat inactivation. We
showed that the L95R mutation impaired HIV-1 repli-
cation by reducing surface expression and virion in-
corporation of the env glycoprotein. The findings dem-
onstrate that the L95 residue in the leucine zipper
motif of gp41c plays an important role in the surface
expression and incorporation of env proteins into in-
fectious HIV-1 virions, which is required for efficient
HIV-1 replication and pathogenesis in vivo.
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ell type-dependent phenotypes of the L95R mutant
A putative leucine zipper (LZ) motif (LX6LX6LX6L) within
he cytoplasmic domain of gp41 (gp41c) of HIV-1 is con-
erved in all HIV-1 subtypes in the Los Alamos HIV
atabases. This LZ motif, however, is not present in the
IV-2 or SIV transmembrane proteins (data not shown).
o examine the function of the leuzine zipper motif within
he cytoplasmic domain of HIV-1 gp41, a point mutation
L95R) was introduced at amino acid position 95 of gp41c
Fig. 1a). L95 is the second leucine within the putative
eucine zipper motif. The L95R mutation did not affect the
mino acid coded in the overlapping rev open reading
rame.
To compare the replication activity of the mutant L95R
irus with that of wild-type NL4-3 virus, human T-lym-
hoid cell lines and phytohemagglutinin (PHA)-stimu-
ated PBMC were infected and virus replication was
FIG. 1. Introduction of a mutation in the leucine zipper motif of the cyt
peptide; TM, transmembrane domain; LLP1 and LLP2, lentivirus lyti
cytoplasmic domain of HIV-1 gp41 (gp41c). The LZ motif is shown i
highlighted. The numbers 512–854 indicate residue positions in the HIV
The numbers 8592–8619 indicate nucleotide positions in the NL4-3 ge
CEMx174 cells were infected with equivalent RT units of NL4-3 or L95R
postinfection. The data are representative of three (PBMC) or four (T-conitored by measuring reverse transcriptase (RT) ac-
ivity in the culture supernatants. L95R replication wasmpaired in SupT1 (Fig. 1b), Jurkat, and H9 cell lines
Zhang et al., 1999). However, L95R showed no observ-
ble replication defect in PHA-activated PBMC and
EMx174 cells (Fig. 1b). L95R virus reached similar peak
T activity at a rate equivalent to that of NL4-3. The
esults suggest that the leucine zipper of gp41c plays a
ole in cell type-dependent HIV-1 replication in vitro.
mpaired HIV-1 replication and pathogenicity of L95R
n the SCID-hu Thy/Liv mouse
To examine the possible replication defect of the L95R
utant in vivo, SCID-hu Thy/Liv mice were infected with
quivalent infectious units of NL4-3 or L95R. NL4-3 virus
eplication was detected at 2 weeks postinfection (wpi)
nd peaked at 4 wpi, with an average p24 level of 1037
g per 106 thymocytes at 2 wpi and 3085 pg per 106
thymocytes at 4 wpi (Fig. 2a). In contrast, L95R virus
replication was significantly reduced at 2 and 4 wpi, with
6
ic domain of HIV-1 gp41. (a) Functional domains of gp41. Fusion, fusion
des 1 and 2. The numbers 1–151 indicate residue positions in the
e-letter amino acid code, with the leucines comprising the LZ motif
60 env polypeptide. The Rev open reading frame remains unchanged.
b) L95R replication in vitro was cell type-dependent. SupT1, PBMC, or
replication (RT activity) was monitored every 3 days for 15 or 24 days
s) experiments with similar replication kinetics.oplasm
c pepti
n singl
-1 gp1
nome. (an average p24 level of 80 and 660 pg per 10 thymo-
cytes, respectively (Fig. 2a). In accordance with the p24
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210 KAO, MILLER, AND SUdata, L95R failed to induce MHC I expression at 2 wpi
and induced lower levels at 4 wpi (data not shown),
which is accompanied by HIV-1 replication in the
SCID-hu Thy/Liv mouse (Kovalev et al., 1999).
NL4-3 virus replication is accompanied by preferential
epletion of CD41CD81 and CD41CD82 thymocytes (Su
t al., 1995). In parallel to impaired virus replication,
athogenesis of L95R was impaired (Figs. 2b and 2c). At
wpi, the percentage of total CD41 thymocytes in NL4-
3-infected Thy/Liv organs decreased significantly (P ,
0.001) compared with that of mock-infected Thy/Liv or-
gans (set at 100%). On the other hand, L95R induced no
significant thymocyte depletion by 4 wpi (Figs. 2b and
2c). For example, the total CD41 thymocytes of NL4-3-
nfected Thy/Liv organs decreased to about 40% of mock-
nfected Thy/Liv organs at 4 wpi. In contrast, the L95R-
FIG. 2. L95R replication/pathogenesis was impaired in the SCID-hu T
mice were infected with equivalent infectious units of NL4-3 or L95R.
The data are representative of three independent experiments with 8–1
(b) HIV-1 pathogenesis in SCID-hu Thy/Liv mice. Pathogenesis was
hymocytes. Values for NL4-3- and L95R-infected Thy/Liv organs are pr
epresent standard errors from 8–10 SCID-hu mice. (c) A representa
hymocyte depletion by NL4-3 and L95R at 4 wpi in comparison to monfecteed Thy/Liv organs showed no significant de-
rease in CD41 thymocyte populations, compared withmock-infecteed Thy/Liv organs. L95R was also impaired
in other measurements of pathogenesis, including a de-
crease in the total percentage of live cells (based on light
scatter profiles) and inversion of the CD4/CD8 ratio (Fig.
2c, and data not shown). Therefore, the L95 residue in
the LZ motif of gp41c was required for efficient HIV-1
replication and pathogenesis in vivo.
The L95R mutant env protein did not affect the early
stage of the virus life cycle and L95R virions showed
similar sensitivity to heat inactivation
A single-cycle infectivity assay was performed using
pseudotyped viruses generated from an env expression
vector and an env-deficient HIV-1 provirus containing a
luciferase reporter gene, NL4-luc-R2E2 (Connor et al.,
mouse. (a) HIV-1 replication in SCID-hu Thy/Liv mice. SCID-hu Thy/Liv
plication (p24, pg/106 thymocytes) was monitored following infection.
-hu Thy/Liv mice for each virus. Error bars represent standard errors.
ined by the percentage of total CD41 (CD41CD81 and CD41CD82)
d relative to the mock-infected Thy/Liv organ (set as 100%). Error bars
CS analysis of CD4/CD8 staining is shown to illustrate the relative
ction.hy/Liv
Virus re
0 SCID
determ
esente1995). This infectivity assay assesses the ability of the
env protein to mediate binding, fusion, and uncoating of
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211THE CYTOPLASMIC LZ DOMAIN OF gp41 ON HIV-1 VIRION INFECTIVITY IN VIVOthe pseudotyped virion in the context of virus-to-cell
transmission. SupT1 or CEMx174 cells were infected
with equivalent infectious units of the pseudotyped vi-
ruses produced from 293T cells and luciferase expres-
sion was assayed at 2 days postinfection (dpi). The
L95R-env pseudotyped virus was able to produce levels
of luciferase equivalent to that of NL4-3 in SupT1 cells
(Fig. 3, left). Similar results were obtained in CEMx174
cells (Fig. 3, right). Virus stocks derived from either de-
fective provirus (NL4-luc-R2E2) or env (pcDNA3-env)
lone were not infectious (data not shown). These data
uggest that the L95R mutant env functioned normally in
he pseudotyped viruses when expressed from a CMV
romoter.
We tested the stability of L95R virions to heat inacti-
ation by incubating NL4-3 and L95R virions at various
emperatures (Fig. 4). Both NL4-3 and L95R virions were
imilarly heat-inactivated at 41 to 49°C and completely
nactivated at 53 and 57°C. These results suggest that
95R virions, once assembled and released, were simi-
arly sensitive to heat inactivation in comparison to wild-
ype virions.
he L95R mutation reduced surface expression of the
p120 env glycoprotein
To determine the expression and subcellular localiza-
ion of L95R mutant glycoproteins, surface expression of
p120 and intracellular expression of gp120 and gp41
ere studied by indirect immunofluorescence (Fig. 5a).
93T cells transfected with NL4-3 or L95R proviral DNA
howed no discernible differences in subcellular local-
zation of gp120 or gp41.
Cell surface expression of gp120 was measured by
FIG. 3. NL4-3 and L95R env-pseudotyped virions showed similar
reporter gene expression in the single-round replication assay. 293T
cells were cotransfected with NL4-luc-R-E- and NL4-3- or L95R-env
expressing plasmids. SupT1 or CEMx174 cells were infected with
equivalent infectious units of viruses pseudotyped with NL4-3 or L95R
env glycoproteins. Results are representative of three independent
experiments with duplicate samples. Error bars represent standard
errors.ACS analysis of T cells infected with VSV G-
seudotyped NL4-3 and L95R viruses (Fig. 5b). BothEMx174 and SupT1 cells infected with L95R showed
ecreased levels of cell surface expression of gp120
ompared to NL4-3-infected cells. A twofold reduction of
ean fluorescence intensity (MFI) was reproducibly ob-
erved in both CEMx174 and SupT1 cells. The data
uggest that the L95R mutation reduced the cell surface
xpression of env glycoproteins.
95R produced more defective particles
T-cell lines and 293T cells were transfected with pro-
iral DNA and culture supernatants were analyzed by RT
total virions) and infectious unit (IU, infectious virions)
ssays. Transfection of L95R proviral DNA into 293T cells
ielded comparable reverse RT activity (total virions) in
ulture supernatants to that of wild-type NL4-3 (data not
hown). However, L95R viral stocks contained 32% less
U than NL4-3 viral stocks (P , 0.01), indicating that
L95R produced more defective viral particles than NL4-3
(Fig. 6a). Transfection of L95R proviral DNA in SupT1 and
CEMx174 cells also yielded RT activity equivalent to
transfection of NL4-3 provirus, suggesting that the L95R
mutant did not affect the expression, assembly, and re-
lease of total viral particles (data not shown). However,
L95R produced significantly less infectious units in
SupT1 (70% reduction) or CEMx174 (50% reduction) cells,
as indicated by the ratio of IUs to RT units (IU/RT, Fig. 6a).
These data indicate that the L95R mutation affected the
assembly or stability of infectious virions.
FIG. 4. NL4-3 and L95R virions showed similar sensitivity to heat
inactivation. Heat inactivation of NL4-3 and L95R virions produced from
293T cells was performed with equal number of IUs. Viral stocks
incubated on ice (0°C) showed no reduction in IUs and were used as
controls (100%). The remaining IU value after heat treatment was
determined and is presented as the percentage IU. The experiment
was performed three times in duplicate.
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incorporation into virions
To examine viral protein expression, virion assembly,
and virion release, cell lysates or pelleted virions from
293T cells transfected with proviral DNA were analyzed
FIG. 5. L95R showed reduced cell surface expression of gp120. (a) S
or L95R provirus DNA was determined. Intracellular gp41 (top) or gp120
microscopy. Mock-transfected cells were used as negative controls. (b
were infected with VSV G-pseudotyped NL4-3 or L95R viruses. Cell su
MFI is presented and standard errors (SE) are shown. MFI from each c
cells (MFI is set to 0). Three independent experiments were performeby Western blot using antibodies specific for gp41, gp120,
or p24 (Fig. 6b and Table 1). Comparable levels of cell-associated gp41 and gp120 (relative to levels of p24/p25)
were synthesized upon transfection of NL4-3 and L95R
proviruses, indicating that the L95R mutation did not
significantly affect the synthesis and proteolytic cleavage
of the env precursor. Virions in culture supernatants
lar distribution of gp120 and gp41 in 293T cells transfected with NL4-3
le) or surface gp120 (bottom) was visualized by standard fluorescence
analysis of cell surface expression of gp120. CEMx174 or SupT1 cells
p120 levels were measured by FACS with an anti-gp120 antibody. The
ple using an isotype control antibody was the same as mock-infected
similar results.ubcellu
(midd
) FACS
rface gwere pelleted by centrifugation in a 20% sucrose cushion
and also analyzed by Western blot. Relative to p24 levels,
o
v
C
s
s
s
d
gp41, gp120, or p24. The positions of gp160, gp120, gp41, and p24 are
indicated. The experiment was repeated three times with similar results.
m
213THE CYTOPLASMIC LZ DOMAIN OF gp41 ON HIV-1 VIRION INFECTIVITY IN VIVOL95R virions contained approximately two- to fivefold
less gp41 and gp120 than NL4-3 virions, suggesting a
possible defect in virion incorporation of gp120/gp41
(Table 1).
DISCUSSION
The L95R mutant was constructed to investigate the
role of a leucine zipper motif in gp41c in HIV-1 replication
and pathogenesis. We report that the L95R mutation in
the leucine zipper motif in gp41c impaired HIV-1 replica-
tion and pathogenesis in vivo by reducing the surface
expression and virion incorporation of env glycoproteins.
L95R replicated to wild-type levels in PHA-stimulated
PBMC and CEMx174 cells, but was impaired in SupT1,
Jurkat, and H9 cell lines (Fig. 1 and Zhang et al., 1999). In
two recent reports, gp41c deletion or truncation mutants
replicate in a cell type-dependent manner in vitro prob-
ably due to defective env incorporation in virions (Akari et
al., 2000; Murakami and Freed, 2000). Using a truncation
mutant lacking all but six amino acids in gp41c, Mu-
rakami and Freed (2000) have recently reported a similar
replication-defective phenotype as L95R in Jurkat and
SupT1 cells. This mutant replicates to wild-type levels in
MT-4 cells. In contrast to L95R, however, this and other
gp41c truncation mutants are also unable to replicate in
PBMC (Dubay et al., 1992; Murakami and Freed, 2000; Yu
et al., 1993). The discrepancy between gp41c truncation
mutants and L95R may be because the truncation mu-
tants also lack potential functional domains in addition to
the leucine zipper in gp41c. It is possible that replication
in PBMC, unlike that in Jurkat and SupT1 cells, requires
functional motifs in gp41c other than the leucine zipper.
This difference between the L95R mutant and the gp41c
truncation mutants also suggests that the L95R mutation
probably disrupted a specific functional domain (LZ) of
gp41c, but not the entire gp41c structure.
L95R replication was impaired in the SCID-hu Thy/Liv
model (Fig. 2) or in the human fetal thymus organ culture
(HF-TOC) model (S. Kao and L. Su, unpublished results).
TABLE 1
HIV-1 gp120/p24 and gp41/p24 Ratios
Proteinsa C-NL4-3b C-L95R V-NL4-3 V-L95R
gp120/p24 0.31 (0.13)c 0.2 (0.08) 0.34 (0.05) 0.07 (0.05)
gp41/p24 0.77 (0.25) 0.85 (0.31) 0.57 (0.12) 0.28 (0.11)
a The level of each protein was calculated by densitometry.
b Cell-associated (C-) or virion-associated (V-) proteins were deter-
ined by densitometry.
c Standard deviations from multiple exposures of two experiments
are shown in parentheses.FIG. 6. L95R produced more defective virions with reduced incorporation
f env glycoproteins. (a) L95R produced more defective particles than NL4-3 in
arious cell lines. NL4-3 and L95R proviruses were transfected into 293T,
EMx174, and SupT1 T cells. Total virions were measured by RT activity in the
upernatants and infectious virions (IU) were titered by MAGI assays. Data
hown are the average of four independent experiments. Error bars represent
tandard errors. The IU/RT ratio of NL4-3 was set to 100%. A significant
ifference is observed between NL4-3 and L95R using Student’s T test
(P , 0.01). (b) L95R virions showed decreased env glycoproteins. Cell
lysates and purified virions (pellet) were blotted with antibodies specific forThe in vivo models entail virus replication in a repertoire
of cell types. The reduced pathogenic effects of L95R
214 KAO, MILLER, AND SUwere likely a consequence of reduced replication since
the L95R replication level was generally below the
threshold of thymocyte depletion mediated by NL4-3 (Su
et al., 1995). In the SCID-hu Thy/Liv mice with higher
levels of L95R replication, reduction in cytopathic effects
in L95R-infected SCID-hu Thy/Liv mice was proportional
to reduction in HIV-1 replication (Fig. 2; and data not
shown).
The block in L95R virus replication may occur after
HIV-1 gene expression since L95R-env pseudotyped viri-
ons were able to undergo a single round of replication at
wild-type levels in both SupT1 and CEMx174 cells (Fig. 3).
It is possible the L95R replication defect in SupT1 cells
may manifest itself only after multiple rounds of replica-
tion. Alternatively, overexpression of L95R mutant env
from the strong CMV promoter in the pcDNA3 vector in
cotransfected 293T cells may have compensated for the
putative defect. Our preliminary results showed that the
IU/RT ratio of L95R-env pseudotyped viruses was the
same as that for NL4-env pseudotyped viruses (data not
shown). This suggests that one defect of L95R replica-
tion may be in the level of env expression.
The L95R mutation appeared to interfere with enve-
lope glycoprotein surface expression and incorporation
into virions (Figs. 5 and 6). Normal levels of surface env
protein are expressed by some gp41c truncation mutants
(Dubay et al., 1992; Murakami and Freed, 2000; Yu et al.,
1993). However, previous reports have also shown that
truncation of gp41c affects virion incorporation of env
glycoprotein (Akari et al., 2000; Dubay et al., 1992; Mu-
rakami and Freed, 2000). It has been suggested that the
cell type-dependent virion incorporation of env glycopro-
teins of gp41c mutants may result in the cell type-depen-
dent replication phenotype (Akari et al., 2000; Murakami
and Freed, 2000). However, other studies have shown
that gp41c truncation mutations do not affect env glyco-
protein incorporation into virions (Gabuzda et al., 1992;
Johnston et al., 1993; Mammano et al., 1995; Salzwedel et
al., 1993; Wilk et al., 1992). These discrepancies may be
mollified by the specific mutations studied and/or the cell
types used to study the effects of the various mutations
on virus replication.
In this report, we failed to detect any dramatic differ-
ences in permissive (CEMx174) and restrictive (SupT1)
cell lines either transfected or infected with L95R and
NL4-3. Thus, similar reduction in surface expression of
gp120 (Fig. 5b) and production of defective L95R virions
(Fig. 6a) were detected in CEMx174 and SupT1 cells. The
seemingly less dramatic reduction in IU/RT ratios of
L95R in CEMx174 cells (50% of NL4-3) than in SupT1 cells
(30% of NL4-3) may contribute to the cell type-dependent
replication. The CEMx174 cell line is a fusion product of
the human B-cell line 721.174 and human T-cell line CEM
(Salter et al., 1985). These cells may contain a host factor
(from B cells?) that facilitates virus replication despite
decreased surface expression and virion incorporationof env glycoproteins. Transfection of T cells with proviral
DNA or infection by VSV-G pseudotyped HIV-1 assesses
only a single round of replication. Since L95R replicated
to wild-type levels in CEMx174 cells (Fig. 1) over multiple
rounds of replication, the defect of L95R mutant in
CEMx174 may potentially be compensated for during
cell-to-cell transmissions. Interestingly, the L95R mutant
replication in SupT1 cells was detectable at 21–24 days
postinfection (Fig. 1b). The recovered viruses were not
due to reversion of L95R because they showed replica-
tion kinetics similar to that of the parental L95R in SupT1
cells (S. Kao and L. Su, unpublished results), suggesting
a delayed replication kinetics of L95R in SupT1 cells. In
L95R-infected SCID-hu Thy/Liv organs, decreased env
surface expression and virion incorporation were likely
responsible for the impaired replication and pathogene-
sis (Fig. 2).
The cell type-dependence phenotype of L95R strongly
suggests the involvement of a host factor(s) in mediating
the effects of gp41c. It is of interest that the permissive
PBMC and CEMx174 cells for L95R replication are also
permissive for wild-type SIV replication, whose TM gp41
proteins lack the LZ motif (L. Su, unpublished results).
Both the SIV gp41c and the HIV-1 L95R gp41c failed to
interact with the host protein p115 RhoGEF that interacts
with wild-type HIV-1 gp41c (Zhang et al., 1999). Our data
showed that T-cell lines (SupT1, Jurkat, and H9) and
SCID-hu Thy/Liv organs expressed high levels of p115,
whereas no significant p115 was detected in PHA-acti-
vated PBMC (unpublished results). The interaction of
gp41c with p115 may be important to overcome the
inhibitory effect of p115 and RhoA (Wang et al., 2000).
Other host cell factors may also contribute to the cell
type-dependent replication phenotypes of gp41c mu-
tants. For example, a specific tyrosine-based sorting mo-
tif (YXXO, where X is any amino acid and O is an amino
acid with a bulky hydrophobic side chain) is the principal
motif responsible for the basolateral targeting of env
glycoprotein and polarized budding of viral particles
(Lodge et al., 1997). The interaction of this motif in gp41c
with the AP-2 clathrin complex has been reported to
mediate rapid glycoprotein internalization (Boge et al.,
1998). The gp41c domain has also been shown to inter-
act with a-catenin (Kim et al., 1999), but the biological
significance of the interaction is not clear. Further stud-
ies need to be conducted to determine the relationship
between the host factor(s) and L95R mutant replication.
Understanding the role of the LZ motif in gp41c will help
to elucidate the structure and function of gp41c and
define a novel target for anti-HIV therapy.
MATERIALS AND METHODS
Cells293T and U-373-MAGI-CXCR4 (Vodicka et al., 1997)
cells were maintained in Dulbecco’s modified Eagle’s
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bovine serum (FBS). PBMC and T-cell lines were cultured
in RPMI 1640 containing 10% heat-inactivated FBS. The
CEMx174 cell line is a fusion product of the human B-cell
line 721.174 and human T-cell line CEM (Salter et al.,
1985). The SupT1 cell line is a non-Hodgkin’s T-cell
lymphoma (Smith et al., 1984).
Construction of the L95R mutant
To construct an infectious NL4-3 proviral clone con-
taining the L95R mutation in gp41, primers with the intro-
duced mutation (nt 8590–8637) were used to perform
site-directed mutagenesis using the QuikChange Site-
Directed Mutagenesis protocol (Stratagene). The mu-
tated HIV-1 fragment was sequenced and cloned into the
proviral DNA clone pNL4-3 (Adachi et al., 1986).
DNA transfection
293T cells were transfected with NL4-3 or L95R pro-
viral DNA using Effectene (Qiagen). To transfect various
T-cell lines, cells were electroporated using a Gene
Pulser (Bio-Rad) at 0.2 kV and 960 mF. Culture superna-
ant was harvested 48 h posttransfection (hpt) and total
irions were measured by RT activity (Buckheit and
wanstrom, 1991). The infectious virion was titered on
-373-MAGI-CXCR4 indicator cells.
iral replication in vitro
Relative virus infectivity was assayed in PHA-activated
BMC, CEMx174, and SupT1 cells. A total of 5 3 105 cells
were infected with viral supernatants containing 105 RT
nits. Culture supernatants were monitored for RT activ-
ty every 3 days.
IV-1 replication and pathogenesis in SCID-hu Thy/
iv mice
Infection of SCID-hu Thy/Liv mice was performed as
reviously described (Kovalev et al., 1999; Su et al., 1995).
Pseudotyped virus production and infection
pcENV-NL4 is a pcDNA3-based vector containing the
EcoRI–XhoI fragment of the NL4-3 env gene (H. Zhang
and L. Su, UNC-CH). The EcoRI–XhoI fragment of L95R
was cloned into pcDNA3 to produce the pcENV-L95R
plasmid construct. 293T cells were cotransfected with
0.4 mg each of the env-deficient pNL43-Luc-R2E2 re-
orter genome (Connor et al., 1995) and pcENV-NL4 or
pcENV-L95R env expression vector using Effectene
Transfection Reagent (Qiagen) as described above. Su-
pernatants containing the pseudotyped viruses were col-
lected 48 hpt and analyzed by luciferase, RT, and MAGI
assays.CEMx174 and SupT1 cells were infected for 2–4 h with
supernatants containing equivalent infectious units(MAGI IU, determined as above) of pseudotyped viruses
in the presence of 8 mg/ml polybrene. Cells were then
washed three times with PBS to remove residual virus
particles. Two days postinfection, cells were washed
once with PBS and lysed for luciferase activity.
Heat-stability analysis of HIV-1 stocks
Equal numbers of NL4-3 or L95R infectious units de-
termined on MAGI cells were incubated at the indicated
temperatures for 10 min and the remaining IUs were
determined on U-373-MAGI-CXCR4 indicator cells as
above. Triplicate samples were included in each exper-
iment.
Western blot analysis
Transfected 293T cells were lysed 48 hpt in 0.5%
NP-40 lysis buffer. To detect viral proteins in virions,
supernatants containing viruses were centrifuged for 2 h
at 4°C in a standard 20% sucrose cushion (Akari et al.,
2000). Viral pellets were lysed in 1% Triton X-100 and
analyzed by standard Western blot with anti-gp41 (Aba-
cioglu et al., 1994), anti-gp120 (Chesebro and Wehrly,
1988), and anti-p24 (Chesebro et al., 1992) monoclonal
ntibodies (provided by the NIH AIDS Research and
eference Reagent Program). The relative level of each
rotein was determined by densitometry.
ndirect immunofluorescence
293T cells were transfected with NL4-3 or L95R pro-
iral DNA. At 40 hpt, cells were fixed with 2% parafor-
aldehyde for surface gp120 staining or 2% formalde-
yde 1 0.05% Triton X-100 for intracellular staining of
p41 or gp120.
low cytometric analysis of gp120 cell surface
xpression
For efficient single-cycle HIV-1 replication assays
Bartz et al., 1996), pci-VSV G DNA was cotransfected
ith either NL4-3 or L95R proviral DNA in 293T cells
sing Effectene (Qiagen). Supernatants containing the
SV-G pseudotyped viruses were collected 48 hpt.
upT1 or CEMx174 cell lines were infected with equiva-
ent RT units of VSV G-pseudotyped NL4-3 and L95R
iruses in the presence of 100 ng/ml AMD3100 {1,19-[1,4-
henylenebis(methylene)]-bis-1,4,8,11-tetra-azacyclotet-
adecane} (kindly provided by J. Moore, Aaron Diamond
IDS Research Center, New York) and 8 mg/ml poly-
brene. AMD3100 is a potent inhibitor of entry of CXCR4-
tropic HIV-1 strains (Donzella et al., 1998; Schols et al.,
1997). Cells were then washed three times with PBS and
maintained in medium containing 100 ng/ml AMD3100.
Two days postinfection, cells were stained with an anti-
gp120 antibody (0.5b), which recognizes the V3 loop
region of NL4-3 gp120 (Burkly et al., 1995). Cells were
BB
B
B
C
C
C
216 KAO, MILLER, AND SUthen stained with goat anti-mouse IgG-FITC. Mouse
IgG2b was used as an isotype control for background.
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